- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03409393
Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis (COPUS)
Feasibility and Relevance of High-Intensity Functional Training in Patients Undergoing Specialised Early Intervention Treatment for First-Episode Psychosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The introduction of specialized early intervention (SEI) is stated to be the most successful recent addition to the treatment of schizophrenia and other psychotic illnesses. In Denmark, SEI teams called OPUS, offer early intervention treatment (i.e. OPUS treatment) to young patients between 18 and 35 years with first-episode psychosis. The OPUS treatment consists of three main pillars: modified assertive treatment, family involvement, and social skill training. OPUS treatment is delivered via multidisciplinary teams including psychiatrists, psychologists, nurses, social workers, physiotherapists, and vocational therapists.
Despite considerable progress in treatment of schizophrenia, people diagnosed with schizophrenia live significantly shorter lives, compared to the rest of the population. The higher mortality rate can be partly explained by an increased risk of cardiovascular disease, including metabolic syndrome, which may be documented already in the first months after start of medical anti-psychotic treatment. It is widely acknowledged that physical activity constitutes a cornerstone in the prevention of cardiovascular disease and metabolic syndrome. Therefore, despite the influence of non-modifiable factors (e.g. genetics), it is reasonable to assume that physical activity can promote health and prevent somatic disease in people diagnosed with schizophrenia.
However, currently, physical activity is not included in early intervention treatment of schizophrenia. Moreover, people with schizophrenia may experience anxiety, loss of motivation, apathy and social isolation, which can constitute significant barriers for adherence to physical activity. Existing knowledge in relation to physical activity behaviour change and adoption is therefore difficult to transfer directly to people with schizophrenia. Development and testing of new initiatives, which can be integrated into clinical practice, and offered complementary to SEI are thus warranted.
Against this background, the aim of the current study (called the COPUS study) is to investigate, whether it is possible to recruit and retain young people with first-episode psychosis, to an 8-weeks supervised High-Intensity Functional Training (HIFT) intervention (i.e. COPUS intervention) and to investigate if oxygen uptake, body composition and physical function changes following participation in the COPUS intervention. The study is organized as a randomized mixed methods feasibility study.
The COPUS intervention is offered in a private fitness centre in the local community. The intervention contains three training sessions of one hour duration per week, with the recommendation to the participants, to take part in at least two sessions per week.
The investigators aim to include 30 participants whom will be randomly assigned (1:1) to either an intervention group receiving the COPUS intervention plus usual care (i.e. standard OPUS treatment) or a control group including only receiving usual care (i.e. standard OPUS treatment). Participants allocated to the control group are offered the COPUS intervention after eight weeks.
The design and choice of methods reflect the complexity of the intervention (combination of social and physical elements that are difficult to control and isolate) and the desire to establish a scientifically informed basis for a subsequent, up-scaled, pragmatic randomized multicentre study.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brøndby, Denmark, 2605
- OPUS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18 and 35 years
- Diagnosed with Schizophrenia or Schizotypal disorders
- Undergoing OPUS treatment for at least 6 months or stabilized medical anti-psychotic treatment
- Danish speaking
Exclusion Criteria:
- Physical contraindications for physical activity
- Pregnant (self-reported)
- Unable to give adequately informed consent
- Mentally disabled
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention Group
The COPUS intervention plus usual care (OPUS treatment).
|
The COPUS intervention consists of 8 weeks of High-Intensity Functional Training (HIFT).
The frequency of the training is 3 sessions per week and the duration is one hour per session.
The intervention is group-based and supervised.
Each training session includes warm-up (15 min), followed by 30 minutes of HIFT based on a range of varied functional exercises, including elements of strength training and aerobic exercise.
The sessions are supervised by a trained physiotherapist and exercise physiologist supported by 2 two trained bachelor students in Sports Science.
Usual care include specialised early intervention treatment (OPUS treatment) and consists of three main pillars: modified assertive treatment, family involvement, and social skill training.
OPUS treatment is delivered via multidisciplinary teams include psychiatrists, psychologists, nurses, social workers, physiotherapists, and vocational therapists.
All team members, except for the psychiatrist, function as case managers.
The ratio of patients to case managers must not exceed 12:1.
|
Other: Control Group
Usual care (OPUS treatment).
|
Usual care include specialised early intervention treatment (OPUS treatment) and consists of three main pillars: modified assertive treatment, family involvement, and social skill training.
OPUS treatment is delivered via multidisciplinary teams include psychiatrists, psychologists, nurses, social workers, physiotherapists, and vocational therapists.
All team members, except for the psychiatrist, function as case managers.
The ratio of patients to case managers must not exceed 12:1.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of changes in Physical Fitness (VO2max)
Time Frame: Change from Baseline Physical Fitness (VO2max) at 2 months.
|
Assessed by the maximum amount of oxygen the body can utilize during a specified period of intense exercise.
|
Change from Baseline Physical Fitness (VO2max) at 2 months.
|
Recruitment Rate
Time Frame: Registration of recruitment occurs in the 4 weeks prior to the baseline tests.
|
Registration of patients enrolled in the study compared to the total number of eligible patients.
|
Registration of recruitment occurs in the 4 weeks prior to the baseline tests.
|
Retention Rate
Time Frame: From baseline up to 4 months.
|
Registration of the participants attendance in the High-Intensity Functional Training compared with the number of possible training sessions during the period.
|
From baseline up to 4 months.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of changes in body weight
Time Frame: Change from Baseline Body Weight at 2 months.
|
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining body weight.
|
Change from Baseline Body Weight at 2 months.
|
Assessment of changes in fat percentage
Time Frame: Change from Baseline Fat Percentage at 2 months.
|
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining fat percentage.
|
Change from Baseline Fat Percentage at 2 months.
|
Assessment of changes in bone mass
Time Frame: Change from Baseline Bone Mass at 2 months.
|
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining bone mass.
|
Change from Baseline Bone Mass at 2 months.
|
Assessment of changes in muscle mass
Time Frame: Change from Baseline Muscle Mass at 2 months.
|
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining muscle mass.
|
Change from Baseline Muscle Mass at 2 months.
|
Assessment of changes in Visceral Fat
Time Frame: Change from Baseline Visceral Fat at 2 months.
|
The participants are placed on a bioelectric impedance scale which is a non-invasive valid measurement method for determining visceral fat.
|
Change from Baseline Visceral Fat at 2 months.
|
Assessment of changes in Resting Blood Pressure
Time Frame: Change form Baseline Resting Blood Pressure at 2 months.
|
The participants' Resting Blood Pressure are tested according to the American Heart Association practice guidelines for blood pressure Measurement.
|
Change form Baseline Resting Blood Pressure at 2 months.
|
Assessment of changes in countermovement jump height
Time Frame: Change form Baseline Jump Height at 2 months.
|
Determination of potential changes in countermovement jump height measured using the non-invasive Optojump system (www.optojump.com)
|
Change form Baseline Jump Height at 2 months.
|
Assessment of changes in Leg Muscle Strength
Time Frame: Change form Baseline Leg Muscle Strength at 2 months.
|
Determination of potential changes in leg muscle strength by the non-invasive 30-Second Chair Stand test.
The test measures how many times the participant can reach a full standing position from a sitting position in 30 seconds.
Score range from 0 and up with a higher score being considered as a better outcome.
|
Change form Baseline Leg Muscle Strength at 2 months.
|
Assessment of changes in Hand Grip Strength
Time Frame: Change form Baseline Hand Grip Strength at 2 months.
|
Determination of potential changes in grip strength measured quantitatively using a hand dynamometer.
|
Change form Baseline Hand Grip Strength at 2 months.
|
Assessment of changes in Balance
Time Frame: Change form Baseline balance at 2 months.
|
Determination of potential changes in balance using the Flamingo Balance Test.
The participant stands on a 3 centimeter wide beam while holding the instructors hand.
The tests then measures how many times the participant loses balance in 60 seconds.Score range from 0 and up with a lower score being considered as a better outcome.
|
Change form Baseline balance at 2 months.
|
Assessment of changes in Self-reported Physical Activity Behavior
Time Frame: Change from Baseline Physical Activity Behaviour at 2 months.
|
Assesment of changes in self-reported physical activity behaviour using the Physical Activity Scale (PAS).
The PAS measures self-reported amount of time spent on different physical activities, such as sports, work, and leisure time during 24 hours on an average weekday.
The activities are organized in nine different metabolic equivalent (MET) levels ranging from sleep/rest (0.9 METs) to high-intensity physical activities (>6 METs).
MET is the Metabolic Equivalent of Task and is a physiological measure expressing the energy cost of physical activities and is defined as the ratio of metabolic rate (and therefore the rate of energy consumption) during a specific physical activity to a reference metabolic rate.
Therefore, higher MET scores in the Physical Activity Scale indicates a better outcome than lower scores.
|
Change from Baseline Physical Activity Behaviour at 2 months.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Monitoring of training intensity (for the Intervention Group only)
Time Frame: Through study completion, an average of 4 months
|
Determination of whether the training intensity is adequate to increase Physical Fitness, the workload during training is continuously measured.
A validated device called Actiheart which is both an accelerometer and a heart rate monitor is used to measure workload.
|
Through study completion, an average of 4 months
|
Adverse events
Time Frame: Through study completion, an average of 4 months
|
We will continuously record adverse events that may arise as a result of the intervention, including physical damage, discomfort and any deterioration of symptoms.
The adverse events will be registred both in the intervention period and in the Control Group training period.
|
Through study completion, an average of 4 months
|
Resource Consumption
Time Frame: Through study completion, an average of 4 months
|
In order to evaluate the sustainability of the intervention, we want to register how much time (in minutes) OPUS staff spends on the project
|
Through study completion, an average of 4 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Julie Midtgaard, Ph.D., The University Hospitals Centre for Health Research (UCSF) / Copenhagen University Hospital (Rigshospitalet)
- Study Director: Helle Schnor, Ph.D., Mental health services in the Capital Region of Denmark, Psychiatric Center Glostrup
Publications and helpful links
General Publications
- Midtgaard J, Schnor H, Bjerre ED, Jespersen T, Jelsøe N, Frølund N, Seier S, Rønbøg JW, Nordsborg NB, Ebdrup BH. Exercise training complementary to specialised early intervention in patients with first-episode psychosis: a feasibility randomised trial. Pilot Feasibility Stud. 2021 Aug 19;7(1):162. doi: 10.1186/s40814-021-00900-5.
- Larsen LQ, Schnor H, Tersbol BP, Ebdrup BH, Nordsborg NB, Midtgaard J. The impact of exercise training complementary to early intervention in patients with first-episode psychosis: a qualitative sub-study from a randomized controlled feasibility trial. BMC Psychiatry. 2019 Jun 21;19(1):192. doi: 10.1186/s12888-019-2179-3.
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- COPUS
- 119481 (Other Grant/Funding Number: TrygFonden)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychotic Disorders
-
Medical College of WisconsinCompletedSchizophrenia | Affective Disorders | Psychotic Disorder | Psychotic Mood Disorder
-
Søren Dinesen ØstergaardCompletedAffective Disorders, PsychoticDenmark
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
VA Office of Research and DevelopmentNot yet recruitingMI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMIHomelessness | Schizophrenia Spectrum Disorders | Psychotic Mood Disorders | Psychotic Affective Disorders | Ill-Housed PersonsUnited States
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Centre hospitalier de Ville-Evrard, FranceRecruiting
-
University of MinnesotaUniversity of California, San FranciscoCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Cognitive Impairment | Psychosis | Treatment | Psychotic Depression | Psychotic Episode | Active Control | Psychotic Mood DisordersUnited States
-
University Hospital, CaenRecruiting
-
University of California, San DiegoActive, not recruitingSchizophrenia | Schizoaffective Disorder | Mood Disorder, PsychoticUnited States
-
Boston Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical CenterCompletedPsychotic Disorders | Psychosis | Psychotic EpisodeUnited States
Clinical Trials on The COPUS intervention
-
Qianfoshan HospitalNot yet recruitingUltrasonography | Breast Carcinoma | Breast Neoplasm Female | Health Education
-
Ondokuz Mayıs UniversityCompleted
-
Tel Aviv UniversityCompleted
-
NORCE Norwegian Research Centre ASThe Hospital of VestfoldCompletedMental Disorders | Depression | Back Pain | AnxietyNorway
-
M.D. Anderson Cancer CenterRecruitingPain | Pain Syndrome | Symptom ManagementUnited States
-
Children's Hospital of Fudan UniversityNational Key Research and Development Program of ChinaCompletedAutism Spectrum Disorder | Attention Deficit-Hyperactivity Disorder | Global Developmental Delay | Brain Developmental DiseasesChina
-
University of AarhusAarhus County, DenmarkCompleted
-
Huazhong University of Science and TechnologyWuhan No.1 HospitalRecruitingStress, Psychological | Autonomic Nervous System Diseases | Emotional StressChina
-
Emory UniversityCompleted
-
Taipei Medical UniversityActive, not recruitingEmotional Disorder | Neurodevelopmental Disorders | Behavior DisordersTaiwan